Search results
ASCCP recently released its Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. The new consensus guidelines were developed with input from 19 stakeholder organizations, including ACOG.
- Updated Cervical Cancer Screening Guidelines - ACOG
The adoption of the USPSTF guidelines expands the...
- Updated Cervical Cancer Screening Guidelines - ACOG
The adoption of the USPSTF guidelines expands the recommended options for cervical cancer screening in average-risk individuals aged 30 years and older to include screening every 5 years with primary high-risk human papillomavirus (hrHPV) testing.
Updated US consensus guidelines for management of cervical screening abnormalities are needed to accommodate the 3 available cervical screening strategies: primary human papillomavirus (HPV) screening, cotesting with HPV testing and cervical cytology, and cer-vical cytology alone.
19 wrz 2024 · Read the new ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The updated management guidelines aim to: Allow for a more complete and precise estimation of risk; Provide more appropriate intervention for high-risk individuals ; Recommend less intervention for low-risk individuals
Screening recommendations for the identification of precursors and prevention of cervical cancer. View Screening Guidelines. Management Guidelines & the Enduring Guidelines Process. Risk-based Management Guidelines for the abnormal screening results, including post-colposcopy or post-treatment scenarios.
Links and resources related to cervical screening, management, and colposcopy guidelines and recommendations.
30 lip 2020 · In this update of the ACS guideline for cervical cancer screening, we recommend that cervical cancer screening should begin in average-risk individuals with a cervix at age 25 years and cease at age 65 years and that the preferred strategy for regular screening is primary HPV testing every 5 years (Table 1).